reblozyl data is strong. prior auth is killing us.

Company: Bristol Myers Squibb

Tags: field, strategy, launch

COMMANDS data is solid. hematologists are receptive. one of the actual bright spots. but payers want ESA failure documented even when the clinical case is clear. escalated 3 times. "we're working on it" every time. need a human not a hotline

13 upvotes · 5 comments